Laxmi Dental Board Approves Proposed ₹48 Crore IPO Proceeds Reallocation

Board approved, subject to shareholder approval, variation of IPO proceeds totaling 48.1 Cr from company and subsidiary machinery purchases to land, building and infrastructure for a dental manufacturing facility of 26.9 Cr and movable assets including machinery of 21.2 Cr, with utilization extended through FY27-FY28. It also allotted 7,911 ESOP shares, increasing outstanding shares to 5,50,29,420. The proposal redirects the remaining IPO funds toward an integrated laboratory and aligner facility, supporting the company's transition from leased sites to owned capacity and advancing its broader capex plan. This is the first formal redeployment of the unutilized proceeds and extends the execution window. Implementation remains subject to shareholder approval, land due diligence, definitive agreements and statutory, regulatory and contractual approvals. Deployment may be delayed or varied, and the board may shift up to 10% between the two new objects; the small ESOP allotment is routine